SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Phil Cressman who wrote (2028)3/21/1999 1:16:00 PM
From: Walter Morton  Read Replies (3) | Respond to of 2742
 
RANDOMIZED PHASE II TRIAL COMPARING FOUR DOSES OF IV IL-1B FOR MELANOMA

Can anybody find the details of this abstract?



To: Phil Cressman who wrote (2028)3/21/1999 10:05:00 PM
From: Steve Harmon  Respond to of 2742
 
I think we all know now why Cistron NEVER did a open market stock buyback...

Cistron would definitely NOT be at .19 cents!



To: Phil Cressman who wrote (2028)3/24/1999 11:56:00 AM
From: Steve Harmon  Respond to of 2742
 
Wonder why the bid on Cistron doesn't go up?

Hmmmm....



To: Phil Cressman who wrote (2028)3/29/1999 1:44:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
The minimum price Cistron will get in a sale is 70 cents! Any Biotech CFO in the country could get that price at any time easy...



To: Phil Cressman who wrote (2028)6/1/1999 2:05:00 PM
From: Walter Morton  Respond to of 2742
 
emedtrade.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News